BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2085982)

  • 41. Prolonged course of Fosfomycin-Trometamol for chronic prostatitis: an unknown good option.
    Denes E
    Scand J Urol; 2021 Aug; 55(4):344-345. PubMed ID: 34060413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fosfomycin trometamol: activity in vitro against urinary tract pathogens.
    Greenwood D
    Infection; 1990; 18 Suppl 2():S60-4. PubMed ID: 2286463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled randomized study comparing amoxycillin and pivmecillinam in adult out-patients presenting with symptoms of acute urinary tract infection.
    Bresky B
    J Antimicrob Chemother; 1977 Jul; 3 Suppl B():121-7. PubMed ID: 330480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fosfomycin trometamol in treatment of uncomplicated lower urinary tract infections in adult women--an overview.
    Naber KG
    Infection; 1992; 20 Suppl 4():S310-2. PubMed ID: 1294524
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of urinary infections with fosfomycin.
    Neuman M; Fluteau G
    Chemotherapy; 1977; 23 Suppl 1():259-64. PubMed ID: 832524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt.
    Scaglione F; Cicchetti F; Demartini G; Arcidiacono M
    Int J Clin Pharmacol Res; 1994; 14(3):107-9. PubMed ID: 7883387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fosfomycin Trometamol versus Comparator Antibiotics for the Treatment of Acute Uncomplicated Urinary Tract Infections in Women: A Systematic Review and Meta-Analysis.
    Cai T; Tamanini I; Tascini C; Köves B; Bonkat G; Gacci M; Novelli A; Horcajada JP; Bjerklund Johansen TE; Zanel G
    J Urol; 2020 Mar; 203(3):570-578. PubMed ID: 31651226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trometamol salt of fosfomycin (Monuril). Preliminary pharmacokinetic and clinical experience in the treatment of urinary tract infections in children.
    Careddu P; Borzani M; Varotto F; Garlaschi L; Fontana P
    Eur Urol; 1987; 13 Suppl 1():114-8. PubMed ID: 3552695
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of fosfomycin trometamol in the management of urinary tract infections in pediatrics.
    Jodal U
    Infection; 1992; 20 Suppl 4():S317-20. PubMed ID: 1294526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The trometamol salt of fosfomycin: microbiological evaluation.
    Greenwood D; Coyle S; Andrew J
    Eur Urol; 1987; 13 Suppl 1():69-75. PubMed ID: 3552702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fosfomycin for UTIs.
    Drug Ther Bull; 2016 Oct; 54(10):114-117. PubMed ID: 27737907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Single oral dose of phosphomycin trometamol versus pipemidic acid and norfloxacin in treating uncomplicated low-level urinary tract infections].
    Cortés R; Pascual T; Lou Arnal S; Orozco F; Sunyer L
    Aten Primaria; 1992 Dec; 10(9):1007-12. PubMed ID: 1467416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A general practitioner multicenter study: fosfomycin trometamol single dose versus pipemidic acid multiple dose.
    Jardin A
    Infection; 1990; 18 Suppl 2():S89-93. PubMed ID: 2286468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Efficiency of fosfomycin trometamol for treatment of acute uncomplicated cystitis].
    Kuzmenko AV; Kuzmenko VV; Gyaurgiev TA
    Urologiia; 2018 Dec; (6):70-75. PubMed ID: 30742381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fosfomycin trometamol single dose: significance and management of lower UTI's.
    Chemotherapy; 1990; 36 Suppl 1():1-55. PubMed ID: 2085980
    [No Abstract]   [Full Text] [Related]  

  • 56. [Randomized comparative study for the assessment of a new therapeutic schedule of fosfomycin trometamol in postmenopausal women with uncomplicated lower urinary tract infection].
    Palou J; Angulo JC; Ramón de Fata F; García-Tello A; González-Enguita C; Boada A; Sanz M;
    Actas Urol Esp; 2013 Mar; 37(3):147-55. PubMed ID: 22995326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral prophylaxis with fosfomycin trometamol in transurethral prostatectomy and urological maneuvers: literature review and personal experience.
    Selvaggi FP; Battaglia M; Grossi FS; Disabato G; Cormio L
    Infection; 1992; 20 Suppl 4():S321-4. PubMed ID: 1294527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Chemoprevention using fosfomycin trometamol in transurethral resection of the prostate: multicenter controlled clinical study].
    Novelli A; Reali EF; Lamanna S; Fontana P; Periti P
    Ann Ist Super Sanita; 1987; 23(4):809-12. PubMed ID: 3330645
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents.
    Carlone NA; Borsotto M; Cuffini AM; Savoia D
    Eur Urol; 1987; 13 Suppl 1():86-91. PubMed ID: 3552703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prophylactic chemotherapy with fosfomycin trometamol versus placebo during transurethral prostatic resection.
    Baert L; Billiet I; Vandepitte J
    Infection; 1990; 18 Suppl 2():S103-6. PubMed ID: 2286454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.